Windtree shareholders approve reverse stock split, reject equity plan increase

WINDTREE THERAPEUTICS INC /DE/

Reverse split approved (ratio 1:5 to 1:50, board discretion) with 2,504,535 for, 1,752,258 against.
Equity plan amendment to increase shares from 41,010 to 1,141,010 failed: 586,282 for, 1,323,734 against, 2,381,134 broker non-votes.
Special meeting held Feb 3, 2025; record date Dec 20, 2024 with 11,048,828 shares outstanding.
Management loses ability to grant additional equity incentives under the 2020 Plan after rejection.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.